Clinical trial
Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic…
NCT00370617 · University of Turin, Italy, Other · Unknown status
Key facts
| NCT number | NCT00370617 |
|---|---|
| Title | Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin Resistance |
| Official title | An Efficacy and Safety Study Comparing Pegylated-Interferon and Ribavirin Plus Metformin to Pegylated-Interferon and Ribavirin in the Treatment of naïve Patients With Genotype 1 Chronic HCV Infection and Insulin Resistance |
| Lead sponsor | University of Turin, Italy, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C, Insulin Resistance |
| Intervention type | Drug |
| Interventions | metformin |
| Enrollment | 200 |
| Start date | Sep 1, 2006 |
| Completion | Jan 1, 2009 |
| First posted | Aug 31, 2006 |
| Last update posted | Nov 14, 2006 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: